Regeneron Pharmaceuticals (NQ: REGN )

624.92 USD +16.20 (+2.66%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 28, 2022 Add to My Watchlist

Price and Volume

Volume	736,706
Open	608.29
Bid (Size)	620.05 (1)
Ask (Size)	630.00 (3)
Prev. Close	608.72
Today's Range	601.89 - 625.00
52wk Range	441.00 - 686.62
Shares Outstanding	91,779,465
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Promising Results Continue to Develop Optimism in Fight Against Cancers

January 27, 2022

Regeneron, Sanofi Withdraw FDA Application For Libtayo's Expanded Use

January 28, 2022

Regeneron Pharmaceuticals Inc(NASDAQ: REGN) and its partnerSanofi SA(NASDAQ: SNY) havevoluntarily withdrawn ...

Performance

YTD	-0.35%	-0.35%
1 Month	-3.45%	-3.45%
3 Month	-2.35%	-2.35%
6 Month	+8.76%	+8.76%
1 Year	+23.44%	+23.44%

More News

The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron

January 28, 2022

Notable ETF Outflow Detected - IUSG, REGN, KLAC, SPGI

January 25, 2022

J&J exec says biotechs aren’t ‘necessarily on sale’ even after a challenging 2021

January 27, 2022

A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of Earnings, Fed Meeting

January 25, 2022

FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why

January 24, 2022

Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments

January 25, 2022

Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments?

January 24, 2022

IBD 50 Stocks To Watch: Biotech Leader Regeneron Eyes New Buy Point In Volatile Market

January 25, 2022

Second Dupixent Phase 3 Trial Confirms Significant Improvements In Inflammatory Skin Disease

January 19, 2022

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Search form

The Statesman Examiner

Regeneron Pharmaceuticals (NQ: REGN )

Price and Volume

Top News

Performance

More News